secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001104659-26-026384
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences receives additional $16.1M from warrant exercises, total $42.6M since Dec 31
--------------------------------------------------------------------------------

- Additional $16.1M in proceeds from warrant exercises since January 8, 2026.
- Total warrant exercise proceeds since Dec 31, 2025: approximately $42.6M.
- Shares outstanding as of March 11, 2026: 179,536,724.
- Previously reported $26.5M in proceeds as of January 8, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926026384/0001104659-26-026384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465926026384/tm268596d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-026384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer